Recent Quotes
My Watchlist
Indicators
Cabling Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bristol-Myers Squibb (NY:BMY)

46.20 +0.27 (+0.58%)
Streaming Delayed Price Updated: 11:07 AM EST, Nov 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bristol-Myers Squibb

< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
82 83 Next >
News headline image
BMY Q1 Earnings Call: Growth Portfolio Offsets Declines, Guidance Raised Amid Pipeline Advancements
Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) reported Q1 CY2025 results exceeding the market’s revenue expectations, but sales fell by 5.6% year on year to $11.2 billion. The company’s... 
Via StockStory
News headline image
Trump's New Drug Pricing Executive Order Could Rattle Pharma Stocks, With Price Cuts Of Up To 80%: Novo Nordisk, Pfizer And J&J Fall In Premarket ↗
What Happened: On Sunday, President Donald Trump announced on Truth Social that he plans to sign what he called the "most consequential executive order" in U.S. history, aimed at lowering prescription... 
Via Benzinga
Topics Government
News headline image
BRISTOL-MYERS SQUIBB CO (NYSE:BMY) stands out as a stock that provides good value for the fundamentals it showcases. ↗
BRISTOL-MYERS SQUIBB CO has a stellar value proposition. NYSE:BMY not only scores well in profitability, solvency, and liquidity but also maintains a very reasonable price point. 
Via Chartmill
News headline image
Earnings Scheduled For April 24, 2025 ↗
 
Via Benzinga
News headline image
3 Healthcare Stocks in Hot Water
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory... 
Via StockStory
Topics Economy Stocks
News headline image
A Look Into Bristol-Myers Squibb Inc's Price Over Earnings ↗
 
Via Benzinga
News headline image
Top gainers and losers in the S&P500 index during Wednesday's after-hours session. ↗
After the conclusion of the US market's regular session on Wednesday, let's examine the after-hours session and unveil the notable S&P500 performers among the top gainers and losers. 
Via Chartmill
News headline image
FDA Expands Surprise Inspections At Foreign Drug And Food Facilities, Targets Double Standards In Overseas Manufacturing Oversight ↗
FDA to increase surprise inspections at foreign facilities as U.S. companies pour billions into domestic drug and device manufacturing. 
Via Benzinga
News headline image
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields ↗
 
Via Benzinga
News headline image
Bristol Myers Squibb Appoints Cari Gallman as Executive Vice President, General Counsel and Chief Policy Officer
From Bristol Myers Squibb
Via Business Wire
News headline image
FDA Pushes Potential Approval For Cytokinetics' Experimental Heart Drug By Three Months ↗
FDA extended the aficamten decision deadline to Dec. 26 after classifying the REMS submission as a major amendment to the NDA review. 
Via Benzinga
News headline image
1 Stock Under $50 with Solid Fundamentals and 2 to Keep Off Your Radar
Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some... 
Via StockStory
News headline image
Bristol-Myers Squibb Co (NYSE:BMY): A High-Yield Dividend Stock Worth Considering ↗
Bristol-Myers Squibb Co (NYSE:BMY): A High-Yield Dividend Stock Worth Considering 
Via Chartmill
News headline image
This High-Yield Pharma Stock Looks Like an Incredible Bargain ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Don’t Be Fooled by the Bounce: The Market Storm Isn’t Over Yet
Recent upticks in the market may disguise the ongoing risks that remain for investors; these factors point to the importance of a defensive strategy. 
Via MarketBeat
Topics Economy Government World Trade
News headline image
Large Cap Biopharmaceutical Update: Mixed Performance As Tariffs Loom ↗
Biopharma stocks rally along with many of our SMID cap trades. The market situation with pharmaceuticals is even more complicated because we started off with legislation (the IRA) trying to curb rising... 
Via Talk Markets
Topics ETFs Stocks / Equities
News headline image
Top 3 Health Care Stocks That May Rocket Higher In April ↗
 
Via Benzinga
News headline image
Pfizer (PFE) Reports Q1: Everything You Need To Know Ahead Of Earnings
Global pharmaceutical company Pfizer (NYSE:PFE) will be reporting earnings tomorrow before market hours. Here’s what you need to know. 
Via StockStory
Topics Government World Trade
News headline image
4 Surefire Dividend Stocks to Buy in the Stock Market Sell-Off ↗
Via The Motley Fool
Topics Economy Intellectual Property World Trade
News headline image
S&P 500 Rallies 2% On Nvidia, Tesla Gains — But Market Mood Stuck In 'Fear' ↗
 
Via Benzinga
Topics Stocks
News headline image
Gold Gains 1%; Bristol Myers Squibb Posts Upbeat Results ↗
 
Via Benzinga
News headline image
Bristol Myers Delivers Upbeat 2025 Forecast Despite China Tariffs Impact ↗
Bristol Myers reported Q1 revenue of $11.2 billion, raised 2025 guidance, and saw strong Growth Portfolio sales offset Legacy product declines. 
Via Benzinga
News headline image
Bristol Myers Reports Upbeat Q1 Earnings, Raises Full-Year Guidance: Retail’s Optimistic ↗
The company now expects full-year diluted EPS in the range of $6.70 to $7.00, up from its previous guidance of $6.55 to $6.85. 
Via Stocktwits
Topics World Trade
News headline image
Bristol Myers Continues A Two-Day Losing Spree Despite Walloping Earnings Estimates ↗
The company recently faced two big clinical trial setbacks that have weighed on shares recently. 
Via Investor's Business Daily
Topics Government
News headline image
Wall Street Rally Extends Into Third Day: What's Driving Markets Thursday? ↗
U.S. equities are pushing higher for a third straight session, eyeing the longest winning streak since the Trump tariff announcement on April 2, as optimism over corporate earnings and easing trade... 
Via Benzinga
Topics Government World Trade
News headline image
Bristol-Myers Squibb (NYSE:BMY) Reports Upbeat Q1, Full-Year Outlook Slightly Exceeds Expectations
Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, but sales fell by 5.6% year on year to $11.2 billion. The company’s... 
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
Bristol Myers Squibb Reports First Quarter Financial Results for 2025
From Bristol Myers Squibb
Via Business Wire
News headline image
US Stock Futures Drop Amid Mixed Signals From White House On US-China Trade: 'Focus On Quality In A Diversified Manner,' Says Expert ↗
U.S. stock futures fell on Thursday after a two-day advance. Futures of major benchmark indices were lower in premarket. 
Via Benzinga
News headline image
PepsiCo, Alphabet And 3 Stocks To Watch Heading Into Thursday ↗
 
Via Benzinga
News headline image
Dow Jumps Over 400 Points Amid China Tariff Hopes, Investor Fear Eases: Greed Index Remains In 'Fear' Zone ↗
 
Via Benzinga
Topics Stocks
< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
82 83 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>